1 / 3

2010 Marketplace Timeline for Generic Drugs

2010 Marketplace Timeline for Generic Drugs. ANDRODERM androgen replacement. EFFEXOR XR depression. ASTELIN allergies. COZAAR/ HYZAAR blood pressure. FEMARA (4Q2010 or 1Q2011) breast cancer. DIASTAT (authorized generic) anxiety. FEMHRT menopause symptoms. FLOMAX BPH. AMERGE

Samuel
Télécharger la présentation

2010 Marketplace Timeline for Generic Drugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 2010 Marketplace Timeline for Generic Drugs ANDRODERM androgen replacement EFFEXOR XR depression ASTELIN allergies COZAAR/ HYZAAR blood pressure FEMARA (4Q2010 or 1Q2011) breast cancer DIASTAT (authorized generic) anxiety FEMHRT menopause symptoms FLOMAX BPH AMERGE migraine DIFFERIN acne ARIMIDEX prostate cancer ARICEPT Alzheimer’s Jul 10 Oct 10 Nov 10 Nov 10 Dec 10 Apr 10 May 10 May 10 Jun 10 Sep 10 Oct 10 Mar 10 VOLTAREN GEL arthritis KADIAN pain Generic Exclusivity Expected Expect 10-20% price reduction Expected Launch Possible Launch Launched Multiple Generic Manufacturers Expect 50-80% price reduction

  2. 2011 Marketplace Timeline for Generic Drugs LIPITOR cholesterol RYTHMOL SR arrhythmias NASACORT AQ allergies ZYPREXA antipsychotic LOTREL (addt’l strengths) blood pressure LEVAQUIN antibiotic CADUET cholesterol/ blood pressure XALATAN glaucoma FEMCON FE birth control Jan 11 Mar 11 Mar 11 Jun 11 Jun 11 Nov11 Oct 11 PATANOL & PATANASE allergies TRICOR 48 mg & 145 mg cholesterol Generic Exclusivity Expected Expect 10-20% price reduction Expected Launch Possible Launch Launched Multiple Generic Manufacturers Expect 50-80% price reduction

  3. 2012 Anticipated Generics • Plavix® (clopidogrel) • Atacand® (candesartan) • Actos® (pioglitazone) • Diovan® and combinations (valsartan) • Geodon® (ziprasidone) • Singulair® (montelukast) • Clarinex® (desloratidine) • Avandia® and combinations (rosiglitazone) • Lexapro® (escitalopram) • Viagra® /Revatio® (sildenafil) • Avapro® (irbesartan) • Seroquel® (quetiapine) • Provigil®(modafinil)

More Related